abstract |
The invention relates to novel uses of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and for conserving blood substitutes. The invention also relates to the use of stimulators and activators of soluble guanylate cyclase combined with PDE 5 inhibitors for treating sickle-cell anemia and conserving blood substitutes. |